PIGNANI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 425
EU - Europa 156
AS - Asia 130
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 714
Nazione #
US - Stati Uniti d'America 422
CN - Cina 77
IT - Italia 75
TR - Turchia 29
DE - Germania 23
PL - Polonia 20
UA - Ucraina 16
SE - Svezia 8
GB - Regno Unito 7
HK - Hong Kong 5
JP - Giappone 5
IR - Iran 4
CA - Canada 3
KR - Corea 3
VN - Vietnam 3
FI - Finlandia 2
NO - Norvegia 2
AU - Australia 1
BR - Brasile 1
FR - Francia 1
GE - Georgia 1
ID - Indonesia 1
MY - Malesia 1
NL - Olanda 1
RU - Federazione Russa 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 714
Città #
Chandler 67
Fairfield 46
Ferrara 33
Izmir 29
Woodbridge 29
Houston 23
Nanjing 20
Warsaw 20
Ann Arbor 19
Wilmington 19
Seattle 17
Ashburn 15
Jacksonville 15
Princeton 14
Cambridge 13
Shanghai 12
New York 11
Milan 10
Dearborn 8
Beijing 7
Piemonte 7
Bremen 6
Bologna 5
Changsha 5
Hebei 5
Cagliari 4
San Diego 4
Chicago 3
Dong Ket 3
Falls Church 3
Ferrara di Monte Baldo 3
Guangzhou 3
Jinan 3
Ningbo 3
Redwood City 3
Toronto 3
Andover 2
Belvedere Spinello 2
Hangzhou 2
Hong Kong 2
Leawood 2
London 2
Nanchang 2
Oslo 2
Seongbuk-gu 2
Tabriz 2
Zhengzhou 2
Augusta 1
Balk 1
Bloemfontein 1
Boardman 1
Chongqing 1
Dundee 1
Fars 1
Glenside 1
Haikou 1
Helsinki 1
Henderson 1
Hounslow 1
Jiaxing 1
Kunming 1
Los Angeles 1
Moscow 1
Nandlstadt 1
Newcastle 1
Paris 1
Persiceto 1
Porto Garibaldi 1
Prescot 1
Qingdao 1
Redmond 1
Rio De Janeiro 1
Sabz 1
San Mateo 1
Seocho 1
Shaoxing 1
Shenyang 1
St Louis 1
Taipei 1
Tianjin 1
Triggiano 1
Varese 1
Totale 547
Nome #
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 142
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 105
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 99
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 66
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 59
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 56
CRISPR activation on coagulation F7 or F8 promoters potentiate trascriptional activity in the normal and mutated gene context 51
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 50
Engineered transcription factors (TALE-TF) as potential therapeutic strategy for coagulation factor deficiencies caused by promoter mutations 42
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 40
Modulation at transcriptional and post-translational level to develop therapeutic approaches for coagulation factor deficiencies 21
Base and Prime editing of DNA as a new therapeutic option for Hemophilia A 15
New Genome Editing Approaches: Base And Prime Editing To Revert Hemophilia A-Causing Point Mutations 6
Totale 752
Categoria #
all - tutte 3.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201975 0 0 0 0 0 0 0 0 0 0 17 58
2019/2020142 38 8 5 18 13 18 13 7 10 5 3 4
2020/2021104 1 4 2 9 4 2 20 17 16 12 11 6
2021/2022106 7 14 1 3 6 5 1 1 5 7 5 51
2022/2023137 13 21 1 20 21 16 11 7 17 1 5 4
2023/202470 7 9 10 2 7 12 5 6 1 6 5 0
Totale 752